Get the latest updates from the Indian stock markets, including Nifty levels, Q1 results, and major corporate actions affecting investor sentiment. Stay ahead with our in-depth analysis and expert insights.
Get insights into the Nifty’s technical charts and learn how to make informed investment decisions with our expert analysis and trading strategies.
The Nifty 50 index is currently locked in a consolidation phase, with the broader range demarcated between 26,220 on the upside and 25,700 on the downside. Here’s what investors can expect from Indian markets.
The combined market valuation of six of the top-10 most-valued firms climbed Rs 75,256.97 crore last week, with Tata Consultancy Services and Infosys emerging as the biggest winners.
Gold and silver prices are expected to take a breather next week as investors turn cautious ahead of key US macroeconomic data, including GDP numbers, while thin year-end trading volumes limit price movements.
SEBI clarifies that there is no change in the existing regulatory framework for short selling, amid media reports of potential changes from December 22, 2025.
The Nifty Pharma index slipped nearly 3% in 2025 due to US pricing pressure, regulatory worries, and trade jitters. However, some pharma stocks delivered double-digit gains, rewarding investors who looked beyond the index.
Asian equity markets are set to climb on hopes of a year-end rally, tracking gains in US stocks. Get the latest updates and insights on the market trends and what they mean for Indian investors.
Oil prices have surged as the US intensifies its blockade on Venezuela, with Indian investors watching closely. Here’s what this means for the Indian stock market and crude oil prices.
Get the latest updates from the Indian stock markets, including Nifty levels, major corporate actions, and news-driven stock movements.